Michael Keith Floyd, MD | |
608 Radam Ln, Austin, TX 78745-1172 | |
(512) 443-5988 | |
(512) 443-5055 |
Full Name | Michael Keith Floyd |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 35 Years |
Location | 608 Radam Ln, Austin, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861445280 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | H8045 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St David's South Austin Medical Center | Austin, TX | Hospital |
Ascension Seton Medical Center Austin | Austin, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Urology Austin Pllc | 7810087905 | 63 |
News Archive
Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a row.
YM BioSciences Inc., announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is in non-small-cell lung cancer (NSCLC) patients who are ineligible for curative treatment and being treated palliatively and the other in patients with brain metastases from NSCLC. Current NSCLC palliative treatment and treatment for brain metastases is radiation alone.
Osaka University researchers use smartphones and machine learning to measure sleep patterns. Despite spending at least one quarter to one third a day sleeping, good sleep can elude many people, and the diagnosis and treatment of sleep disorders remains primitive.
Life Technologies Corporation today announced it has received FDA 510(k) clearance for StemPro MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States.
A statistically determined correlation between radioactive fallout from the Chernobyl accident and an increase in the number of cases of cancer in the exposed areas in Sweden is reported in a study by scientists at Linköping University, Örebro University, and the County Council of Västernorrland County.
› Verified 4 days ago
Entity Name | Urology Austin Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093837312 PECOS PAC ID: 7810087905 Enrollment ID: O20071212000738 |
News Archive
Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a row.
YM BioSciences Inc., announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is in non-small-cell lung cancer (NSCLC) patients who are ineligible for curative treatment and being treated palliatively and the other in patients with brain metastases from NSCLC. Current NSCLC palliative treatment and treatment for brain metastases is radiation alone.
Osaka University researchers use smartphones and machine learning to measure sleep patterns. Despite spending at least one quarter to one third a day sleeping, good sleep can elude many people, and the diagnosis and treatment of sleep disorders remains primitive.
Life Technologies Corporation today announced it has received FDA 510(k) clearance for StemPro MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States.
A statistically determined correlation between radioactive fallout from the Chernobyl accident and an increase in the number of cases of cancer in the exposed areas in Sweden is reported in a study by scientists at Linköping University, Örebro University, and the County Council of Västernorrland County.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Keith Floyd, MD 8240 N Mopac Expy Ste 100, Austin, TX 78759-8869 Ph: (512) 687-1950 | Michael Keith Floyd, MD 608 Radam Ln, Austin, TX 78745-1172 Ph: (512) 443-5988 |
News Archive
Research conducted at University of Nevada, Reno and licensed through the University's Technology Transfer Office is featured in the technology transfer publication "Better World Report" for a remarkable second year in a row.
YM BioSciences Inc., announced that the FDA has advised the Company that it may now enroll patients at US clinical sites into two ongoing randomized, double-blind Phase II trials of its lead product, nimotuzumab. One of the two trials is in non-small-cell lung cancer (NSCLC) patients who are ineligible for curative treatment and being treated palliatively and the other in patients with brain metastases from NSCLC. Current NSCLC palliative treatment and treatment for brain metastases is radiation alone.
Osaka University researchers use smartphones and machine learning to measure sleep patterns. Despite spending at least one quarter to one third a day sleeping, good sleep can elude many people, and the diagnosis and treatment of sleep disorders remains primitive.
Life Technologies Corporation today announced it has received FDA 510(k) clearance for StemPro MSC SFM – a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States.
A statistically determined correlation between radioactive fallout from the Chernobyl accident and an increase in the number of cases of cancer in the exposed areas in Sweden is reported in a study by scientists at Linköping University, Örebro University, and the County Council of Västernorrland County.
› Verified 4 days ago
J Stuart Wolf Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1601 Trinity St, Bldg A, Suite 704f, Austin, TX 78712 Phone: 512-324-7871 Fax: 512-324-7870 | |
Parviz K Kavoussi, MD Urology Medicare: May Accept Medicare Assignments Practice Location: 4303 James Casey St, Suite B, Austin, TX 78745 Phone: 512-444-1414 Fax: 512-326-5319 | |
John Charles Williamson, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 4007 James Casey St, C150, Austin, TX 78745 Phone: 512-443-5988 Fax: 512-443-5055 | |
Win Shun Lai, MD Urology Medicare: Medicare Enrolled Practice Location: 7901 Metropolis Dr, Austin, TX 78744 Phone: 512-823-4745 | |
Dr. Joy Nielsen, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 12221 N Mo Pac Expy, Austin, TX 78758 Phone: 512-901-4021 Fax: 512-901-3921 | |
James Franklin Reeves, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3100 Red River St, Austin, TX 78705 Phone: 512-477-5905 Fax: 512-477-8640 | |
Dr. Melody Ann Denson, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 15534 Ranch Road 620 N Ste 100, Austin, TX 78717 Phone: 512-231-1444 Fax: 512-828-5511 |